Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria.

Correction to: Diabetes Ther (2022) 13:551–567 10.1007/s13300-022-01218-y

In the original article, the second heading in the results section was published incorrectly. The correct heading is “Effectiveness of semaglutide”.